BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

801 related articles for article (PubMed ID: 18721587)

  • 1. Postthymectomy myasthenia gravis: relationship with thymoma and antiacetylcholine receptor antibody.
    Nakajima J; Murakawa T; Fukami T; Sano A; Takamoto S; Ohtsu H
    Ann Thorac Surg; 2008 Sep; 86(3):941-5. PubMed ID: 18721587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma.
    Mygland A; Tysnes OB; Matre R; Volpe P; Aarli JA; Gilhus NE
    Ann Neurol; 1992 Oct; 32(4):589-91. PubMed ID: 1333745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. "Maximal" thymectomy for myasthenia gravis. Results.
    Jaretzki A; Penn AS; Younger DS; Wolff M; Olarte MR; Lovelace RE; Rowland LP
    J Thorac Cardiovasc Surg; 1988 May; 95(5):747-57. PubMed ID: 3361927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Thymectomy in Chinese myasthenia gravis].
    Chiu HC; Hsieh JM; Chen RC; Lin FY
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Feb; 20(1):15-22. PubMed ID: 3595261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myasthenia gravis, thymectomy, and antiacetycholine receptor antibody.
    Bartoccioni E; Scuderi F; Scoppetta C; Evoli A; Tonali P; Guidi L; Bartoloni C; Terranova T
    J Neurol; 1980; 224(1):9-15. PubMed ID: 6157802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Problems of postthymectomy-syndromes, e.g. myasthenia gravis (author's transl)].
    Janzen RW; Lachenmayer L; Fischer K
    Med Klin; 1977 Nov; 72(45):1931-7. PubMed ID: 303737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exacerbation of myasthenia gravis after removal of a thymoma having a membrane phenotype of suppressor T cells.
    Kuroda Y; Oda K; Neshige R; Shibasaki H
    Ann Neurol; 1984 Apr; 15(4):400-2. PubMed ID: 6234854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of myasthenia gravis by extended thymectomy with anterior mediastinal dissection.
    Nussbaum MS; Rosenthal GJ; Samaha FJ; Grinvalsky HT; Quinlan JG; Schmerler M; Fischer JE
    Surgery; 1992 Oct; 112(4):681-7; discussion 687-8. PubMed ID: 1411938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA, anti-DNA, and complement in myasthenia gravis.
    Christiansen FT; Houliston JB; Dawkins RL
    Muscle Nerve; 1978; 1(6):467-70. PubMed ID: 757869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Two cases of post-thymectomy myasthenia gravis].
    Tanimura S; Tomoyasu H; Banaba J; Masaki M; Matsushita H
    Nihon Kyobu Geka Gakkai Zasshi; 1992 Sep; 40(9):1778-83. PubMed ID: 1402200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical analysis of myasthenia gravis accompanied by invasive thymoma].
    Wakata N; Kawamura Y; Shin K; Kobayashi T; Kinoshita M
    Rinsho Shinkeigaku; 1991 Mar; 31(3):260-5. PubMed ID: 1893663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimuscle and antiacetylcholine receptor antibodies in myasthenia gravis.
    Penn AS; Schotland DL; Lamme S
    Muscle Nerve; 1986 Jun; 9(5):407-15. PubMed ID: 3724787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Detection of antibodies to citric acid extract of skeletal muscle (CAE-ab) in the sera of patients with myasthenia gravis using indirect hemagglutination].
    Ma W
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1990 Jun; 23(3):143-5, 189. PubMed ID: 2390884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Germinal centers are associated with postthymectomy myasthenia gravis in patients with thymoma.
    Chung HY; Shin HY; Choi YC; Park HJ; Lee JG; Lee CY; Park BJ; Kim GJ; Kim SW
    Eur J Neurol; 2024 Feb; 31(2):e16119. PubMed ID: 37909803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-acetylcholine receptor antibody titer with extended thymectomy in myasthenia gravis.
    Kagotani K; Monden Y; Nakahara K; Fujii Y; Seike Y; Kitamura S; Masaoka A; Kawashima Y
    J Thorac Cardiovasc Surg; 1985 Jul; 90(1):7-12. PubMed ID: 4010323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myasthenia gravis: prognostic significance of clinical data in the prediction of post-thymectomy respiratory crises.
    Turáni E; Szathmáry I; Molnár J; Szobor A
    Acta Chir Hung; 1992-1993; 33(3-4):353-60. PubMed ID: 1345395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complications and efficacy of transsternal thymectomy in myasthenia gravis.
    Späth G; Brinkmann A; Huth C; Wiethölter H
    Thorac Cardiovasc Surg; 1987 Oct; 35(5):283-9. PubMed ID: 2447670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose intravenous immunoglobulin in the management of myasthenia gravis.
    Arsura EL; Bick A; Brunner NG; Namba T; Grob D
    Arch Intern Med; 1986 Jul; 146(7):1365-8. PubMed ID: 3718134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A case of thymoma with an increased sensitivity to pancuronium].
    Hirai T; Ito M; Abe R
    Nihon Kyobu Geka Gakkai Zasshi; 1990 Jun; 38(6):1059-62. PubMed ID: 2398288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible relationship between poly(ADP-ribose)synthetase and formation of antibody against acetylcholine receptors in patients with myasthenia gravis.
    Aoyagi T; Wada T; Kojima F; Nagai M; Yoshida S; Sato T; Takeuchi T
    Biochem Int; 1989 Feb; 18(2):391-8. PubMed ID: 2504162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.